H.R. 5133
IntroducedAffordable Prescriptions for Patients Through Promoting Competition Act of 2019
Latest Action
Placed on the Union Calendar, Calendar No. 578.
12/24/2020 • House
Summary
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
This bill prohibits, subject to certain exceptions, the practice of product hopping, which is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration's approved drug list, discontinues a drug, or markets a reformulation of an already approved drug during a certain period after which the manufacturer has been notified that a competing drug manufacturer has applied for generic drug approval.
Reported to House • 12/24/2020
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (6)
Party Breakdown
Sponsor
Cosponsors (5)
Bill Journey
Originated in the House
Introduced
November 18, 2019
Committee Review
November 19, 2019
Subcommittee on Antitrust, Commercial, and Administrative Law Discharged.
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law